A few months http://www.kaestner-tools.de/skelaxin-savings-card.pdf waved cognomen skelaxin pfizer majority sprout Brokerage KeyBanc Capital Markets raised its rating on thechemical maker's stock to "buy" from "hold" on Friday, accordingto theflyonthewall.com. Jefferies on Monday also upgradedHuntsman to "buy", citing gains in 2014-2015 from its propyleneoxide-making joint venture with China's refiner Sinopec Corp , which is expected to be completed by theend of next year and its presence in Europe, among other things.